Zobrazeno 1 - 10
of 32
pro vyhledávání: '"P.D. Knoester"'
Autor:
Willy O. Renier, Arjo J. Boendermaker, P.D. Knoester, C.L.P. Deckers, Hans Severens, Toine Keyser, Yechiel A. Hekster, Marc C. T. F. M. de Krom, Eveline H. Termeer, Irene A. W. Kotsopoulos
Publikováno v:
Value in Health, 10, 3, pp. 173-82
Value in Health, 10(3), 173-182. Elsevier Ltd.
Value in Health, 10, 173-82
Value in Health, 10(3), 173-182. Elsevier Ltd.
Value in Health, 10, 173-82
Contains fulltext : 53088.pdf (Publisher’s version ) (Closed access) OBJECTIVE: To establish cost-effectiveness of antiepileptic drug (AED) treatment strategies of newly diagnosed patients with epilepsy. METHODS: A decision analysis was carried out
Autor:
Antoine C. G. Egberts, C.L.P. Deckers, P.D. Knoester, Yechiel A. Hekster, A.J. Boendermaker, Willy O. Renier, Johan L. Severens, Antoine Keyser
Publikováno v:
Epilepsy Research, 67, 143-51
Epilepsy Research, 67, 3, pp. 143-51
Epilepsy Research, 67, 3, pp. 143-51
Contains fulltext : 47543.pdf (Publisher’s version ) (Closed access) OBJECTIVE: This retrospective study addresses the cost-effectiveness of add-on therapy with lamotrigine in clinical practice. METHODS: Two years' observational data of 165 patient
Effectiveness of lamotrigine in clinical practice: results of a retrospective population-based study
Autor:
Antoine C. G. Egberts, Yechiel A. Hekster, Antoine Keyser, Willy O. Renier, C.L.P. Deckers, P.D. Knoester
Publikováno v:
Epilepsy Research, 65, 1-2, pp. 93-100
Epilepsy Research, 65, 93-100
Epilepsy Research, 65, 93-100
Contains fulltext : 47617.pdf (Publisher’s version ) (Closed access) OBJECTIVE: Evaluation of the effectiveness of lamotrigine in a population-based cohort of epilepsy patients. METHODS: Medical charts of 360 patients treated in 37 centres in The N
Autor:
P.D. Knoester, Antoine Keyser, Willy O. Renier, G. J. De Haan, Yechiel A. Hekster, C.L.P. Deckers
Publikováno v:
CNS Drugs, 17, 405-21
CNS Drugs, 17, 6, pp. 405-21
CNS Drugs, 17, 6, pp. 405-21
Item does not contain fulltext In recent years, several new antiepileptic drugs (AEDs) have been licensed: felbamate, gabapentin, lamotrigine, levetiracetam, oxcarbazepine, tiagabine, topiramate, vigabatrin and zonisamide. These drugs have proven eff
Autor:
Peter M. Edelbroek, G. J. Brekelmans, R. T. M. Van Der Hoeven, P.D. Knoester, T. A. C. Vermeij, Daniël M. Jonker, G. J. De Haan
Publikováno v:
British Journal of Clinical Pharmacology. 53:501-507
AIMS: To investigate the pharmacokinetic and pharmacodynamic profile of midazolam administered as a concentrated intranasal spray, compared with intravenous midazolam, in healthy adult subjects. METHODS: Subjects were administered single doses of 5 m
Publikováno v:
Health Policy, 78, 353-9
Health Policy, 78, 2-3, pp. 353-9
Health Policy, 78, 2-3, pp. 353-9
Contains fulltext : 49576.pdf (Publisher’s version ) (Closed access) In 1997, the National Health Insurance Board of the Netherlands (CVZ) introduced a guideline for the use of a new anti-epileptic drug, Lamotrigine. The goal was to limit the use o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9be6e33abe02129917cfb4e640130148
https://doi.org/10.1016/j.healthpol.2005.11.014
https://doi.org/10.1016/j.healthpol.2005.11.014
Publikováno v:
Pharmacy World and Science, 27, 2, pp. 129-34
Pharmacy World and Science, 27, 129-34
Pharmacy World and Science, 27, 129-34
Item does not contain fulltext OBJECTIVE: In the past decade, several new anti-epileptic drugs (AEDs) were introduced in The Netherlands. These new drugs, one of which is lamotrigine, are 6 to 10 times more expensive than conventional anti-convulsant
Autor:
Svetlana V. Belitser, Antoine C. G. Egberts, C.L.P. Deckers, Yechiel A. Hekster, Antoine Keyser, Willy O. Renier, P.D. Knoester
Publikováno v:
Pharmacoepidemiology and Drug Safety, 14, 107-12
Pharmacoepidemiology and Drug Safety, 14, 2, pp. 107-12
Pharmacoepidemiology and Drug Safety, 14, 2, pp. 107-12
Contains fulltext : 57775.pdf (Publisher’s version ) (Closed access) OBJECTIVE: Community pharmacists may function as intermediaries in the recruitment of a population-based cohort of patients using specific drugs. In this study, baseline character
Autor:
Willy O. Renier, P.D. Knoester, Antoine Keyser, Svetlana V. Belitser, Yechiel A. Hekster, C.L.P. Deckers, Antoine C. G. Egberts
Publikováno v:
Journal of Clinical Pharmacy and Therapeutics, 29, 131-8
Journal of Clinical Pharmacy and Therapeutics, 29, 2, pp. 131-8
Journal of Clinical Pharmacy and Therapeutics, 29, 2, pp. 131-8
Contains fulltext : 59173.pdf (Publisher’s version ) (Closed access) OBJECTIVE: Follow-up data on the long-term effectiveness (efficacy and tolerability) of lamotrigine are limited. A useful though crude measure for effectiveness in daily clinical
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4dc5e50ce93e0765eae988bf2528bef4
http://hdl.handle.net/2066/59173
http://hdl.handle.net/2066/59173
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.